AAPL Apple | Reiterated by | DZ Bank Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $171.55 -1.0% | $180.00 | Buy ➝ Hold | |
ADCT ADC Therapeutics | Initiated by | Guggenheim Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.37 +4.0% | $11.00 | Buy | |
AIN Albany International | Reiterated by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.26 -2.3% | $105.00 ➝ $95.00 | Neutral ➝ Underperform | |
ALL Allstate | Upgraded by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $171.89 +1.2% | $158.00 ➝ $190.00 | Hold ➝ Buy | |
AQMS Aqua Metals | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.50 -4.4% | $4.00 | Buy ➝ Buy | |
AQST Aquestive Therapeutics | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.41 +7.6% | $7.00 | Outperform | |
|
ATEC Alphatec | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.97 +1.2% | $22.00 ➝ $23.00 | Buy ➝ Buy | |
AZTA Azenta | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $59.71 +0.5% | $75.00 | Buy ➝ Buy | |
BAC Bank of America | Reiterated by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $37.77 -0.1% | $38.00 ➝ $39.00 | Buy ➝ Hold | |
BRZE Braze | Reiterated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.71 -11.6% | | Outperform | |
BRZE Braze | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.71 -11.6% | $75.00 | Outperform ➝ Outperform | |
BRZE Braze | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.71 -11.6% | $70.00 ➝ $65.00 | Buy ➝ Buy | |
BRZE Braze | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.71 -11.6% | $70.00 | Buy ➝ Buy | |
BRZE Braze | Reiterated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.71 -11.6% | $66.00 | Overweight ➝ Overweight | |
BSY Bentley Systems | Initiated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $51.94 +0.7% | | Outperform | |
BWXT BWX Technologies | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $102.37 +0.4% | $82.00 ➝ $115.00 | Buy ➝ Buy | |
C Citigroup | Target Raised by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $63.09 +0.5% | $61.00 ➝ $70.00 | Buy ➝ Buy | |
CARA Cara Therapeutics | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.86 -1.0% | $5.00 | Buy ➝ Buy | |
CCL Carnival Co. & | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.85 -2.0% | $24.00 ➝ $25.00 | Overweight ➝ Overweight | |
CCL Carnival Co. & | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.85 -2.0% | $22.00 ➝ $23.00 | Overweight ➝ Overweight | |
CCL Carnival Co. & | Target Raised by | Macquarie Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.85 -2.0% | $22.00 ➝ $24.00 | Outperform ➝ Outperform | |
CELC Celcuity | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $18.59 +2.4% | $23.00 ➝ $24.00 | Buy ➝ Buy | |
CELC Celcuity | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | S. Ramakanth Subscribe to MarketBeat All Access for the recommendation accuracy rating | $18.59 +2.4% | $27.00 | Buy ➝ Buy | |
CLBT Cellebrite DI | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.40 -0.4% | $13.00 ➝ $13.50 | Buy ➝ Buy | |
CLRB Cellectar Biosciences | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.88 +6.6% | $11.00 ➝ $12.00 | Outperform ➝ Outperform | |
CMG Chipotle Mexican Grill | Target Raised by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2,931.10 +0.3% | $2,750.00 ➝ $3,250.00 | Buy ➝ Buy | |
CTAS Cintas | Target Raised by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $686.51 +0.1% | $673.00 ➝ $765.00 | Buy | |
CTAS Cintas | Target Raised by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $686.51 +0.1% | $700.00 ➝ $790.00 | Buy ➝ Buy | |
CTAS Cintas | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $686.51 +0.1% | $660.00 ➝ $750.00 | Outperform ➝ Outperform | |
CXM Sprinklr | Reiterated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.30 +2.2% | | Outperform | |
CXM Sprinklr | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.30 +2.2% | | Market Perform ➝ Market Perform | |
CXM Sprinklr | Target Raised by | Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.30 +2.2% | $16.00 ➝ $18.00 | Buy ➝ Buy | |
CYBR CyberArk Software | Initiated by | BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $264.83 +0.6% | $317.00 | Buy | |
DKNG DraftKings | Target Raised by | Moffett Nathanson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.98 -0.8% | $52.00 ➝ $55.00 | Buy ➝ Buy | |
DOYU DouYu International | Target Lowered by | Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.70 -1.4% | $7.00 ➝ $6.00 | Sell ➝ Sell | |
DRRX DURECT | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | E. Arce Subscribe to MarketBeat All Access for the recommendation accuracy rating | $1.28 -4.5% | | Neutral | |
EFTR eFFECTOR Therapeutics | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $13.55 +0.7% | $24.00 | Buy ➝ Buy | |
EHC Encompass Health | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $81.16 +4.6% | $95.00 ➝ $101.00 | Overweight ➝ Overweight | |
EL Estée Lauder Companies | Upgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $149.19 +2.9% | $160.00 ➝ $170.00 | Neutral ➝ Buy | |
ENGN enGene | Initiated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $17.55 +1.8% | $37.00 | Buy | |
Warning: this could blow your mind (Ad) Buckle up…
‘Cause this might shatter everything you’ve heard about “income trading”.
In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it:
The Perfect Income Trade
You see, most of the income techniques out there target a couple of percent.
Maybe 5 - 10 percent if you’re lucky.
But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return.
And here’s the best news of all:
This trade can target an opportunity like that every week. Every single week.
Meaning an investor has the chance to “stack up” these more aggressive income trades over and over.
If that sounds interesting… Watch the presentation here |
EOG EOG Resources | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $127.53 +0.9% | $134.00 ➝ $141.00 | Neutral ➝ Neutral | |
ERAS Erasca | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Maldonado Subscribe to MarketBeat All Access for the recommendation accuracy rating | $2.44 +18.6% | $8.00 | Buy ➝ Buy | |
EVH Evolent Health | Target Lowered by | Canaccord Genuity Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.48 -0.8% | $45.00 ➝ $44.00 | Buy ➝ Buy | |
EXR Extra Space Storage | Reiterated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $148.62 +1.3% | $160.00 | Strong-Buy ➝ Outperform | |
FNA Paragon 28 | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.80 -0.9% | $17.00 | Buy ➝ Buy | |
GLPG Galapagos | Reiterated by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.10 -2.6% | $41.00 ➝ $31.00 | Neutral ➝ Underperform | |
GNL Global Net Lease | Initiated by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.68 +0.7% | $7.00 | Hold | |
GRND Grindr | Initiated by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.88 +1.2% | $12.00 | Buy | |
GS The Goldman Sachs Group | Target Raised by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $418.51 +0.8% | $432.00 ➝ $460.00 | Buy ➝ Buy | |
HOOD Robinhood Markets | Target Raised by | KeyCorp Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $20.03 +0.1% | $15.00 ➝ $22.00 | Overweight ➝ Overweight | |
IMVT Immunovant | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $32.52 +3.5% | $50.00 | Outperform | |
JSPR Jasper Therapeutics | Initiated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $30.00 +4.1% | $70.00 | Outperform | |
KBH KB Home | Target Raised by | Keefe, Bruyette & Woods Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $69.84 +0.4% | $67.00 ➝ $77.00 | Market Perform ➝ Market Perform | |
KMB Kimberly-Clark | Upgraded by | Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $128.98 +1.3% | $133.00 ➝ $150.00 | In-Line ➝ Outperform | |
KMB Kimberly-Clark | Target Raised by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $128.98 +1.3% | $134.00 ➝ $146.00 | Hold ➝ Hold | |
KR Kroger | Target Raised by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.22 +0.6% | $60.00 ➝ $62.00 | Outperform ➝ Outperform | |
KRRO Korro Bio | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | M. Kapoor Subscribe to MarketBeat All Access for the recommendation accuracy rating | $88.61 +0.1% | $100.00 ➝ $115.00 | Buy ➝ Buy | |
LE Lands' End | Upgraded by | Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.00 +9.6% | $9.00 ➝ $15.00 | Hold ➝ Buy | |
M Macy's | Reiterated by | Telsey Advisory Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $19.88 +0.2% | $21.00 | Market Perform ➝ Market Perform | |
MGX Metagenomi | Reiterated by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $11.13 +0.4% | $21.00 | Buy ➝ Buy | |
MKC McCormick & Company, Incorporated | Target Raised by | Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $76.95 +1.2% | $71.00 ➝ $76.00 | Equal Weight ➝ Equal Weight | |
MOH Molina Healthcare | Downgraded by | Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $410.80 -1.9% | $439.00 | Neutral ➝ Underperform | |
MREO Mereo BioPharma Group | Target Raised by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.14 +4.7% | $5.00 ➝ $6.00 | Buy ➝ Buy | |
MRNA Moderna | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $109.19 -1.3% | | Hold | |
MRUS Merus | Initiated by | Truist Financial Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.75 -0.4% | $69.00 | Buy | |
MS Morgan Stanley | Target Raised by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $94.13 +0.7% | $96.00 ➝ $100.00 | Hold ➝ Hold | |
NUVB Nuvation Bio | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $3.91 -1.5% | $5.00 ➝ $8.00 | Buy ➝ Buy | |
OBIO Orchestra BioMed | Reiterated by | Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $5.62 +5.8% | $20.00 ➝ $20.00 | Buy ➝ Buy | |
OMC Omnicom Group | Upgraded by | BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $96.83 +1.8% | $115.00 | Neutral ➝ Outperform | |
PAR PAR Technology | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $45.48 +0.9% | $53.00 | Buy ➝ Buy | |
PEB Pebblebrook Hotel Trust | Reiterated by | Compass Point Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.50 -0.5% | $17.00 | Buy ➝ Neutral | |
PLTR Palantir Technologies | Downgraded by | Monness Crespi & Hardt Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $23.95 -2.3% | $20.00 | Neutral ➝ Sell | |
PNC The PNC Financial Services Group | Upgraded by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $160.72 +0.5% | $141.00 ➝ $155.00 | Reduce ➝ Hold | |
POOL Pool | Target Raised by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $404.80 -2.4% | $407.00 ➝ $436.00 | Outperform ➝ Outperform | |
PPTA Perpetua Resources | Target Raised by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $4.20 +1.4% | $10.00 ➝ $10.50 | Buy ➝ Buy | |
PRGS Progress Software | Initiated by | DA Davidson Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $52.63 0.0% | $65.00 | Buy | |
PSA Public Storage | Upgraded by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $289.98 +0.7% | $330.00 | Market Perform ➝ Strong-Buy | |
REE REE Automotive | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | A. Dayal Subscribe to MarketBeat All Access for the recommendation accuracy rating | $5.99 +2.6% | $15.00 | Buy ➝ Buy | |
RH RH | Target Raised by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $331.85 +11.7% | $275.00 ➝ $320.00 | Neutral ➝ Neutral | |
RH RH | Target Raised by | JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $331.85 +11.7% | $329.00 ➝ $345.00 | Overweight ➝ Overweight | |
RH RH | Target Raised by | Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $331.85 +11.7% | $280.00 ➝ $300.00 | Neutral ➝ Neutral | |
ROAD Construction Partners | Downgraded by | Sidoti Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $56.63 -1.3% | $59.00 | Buy ➝ Neutral | |
RUM Rumble | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $7.81 -8.1% | | Market Perform ➝ Market Perform | |
SIBN SI-BONE | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.26 +2.8% | $25.00 | Overweight | |
SLDB Solid Biosciences | Reiterated by | William Blair Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $14.74 +3.4% | | Outperform | |
SLE Super League Enterprise | Reiterated by | HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.31 -7.6% | $3.00 | Buy ➝ Buy | |
SPXC SPX Technologies | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $121.42 +0.6% | $124.00 ➝ $134.00 | Outperform ➝ Outperform | |
SRRK Scholar Rock | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.50 +6.8% | $30.00 | Strong-Buy | |
TBRG TruBridge | Initiated by | Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.67 +1.2% | $13.00 | Outperform | |
TFC Truist Financial | Target Raised by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $39.20 +1.6% | $37.00 ➝ $39.00 | Hold ➝ Hold | |
Warning: this could blow your mind (Ad) Buckle up…
‘Cause this might shatter everything you’ve heard about “income trading”.
In fact, it’s such an extreme diversion from what most people think of typical income trades that I call it:
The Perfect Income Trade
You see, most of the income techniques out there target a couple of percent.
Maybe 5 - 10 percent if you’re lucky.
But this new way of trading income on the world’s top stocks goes after more than 10x that kind of return.
And here’s the best news of all:
This trade can target an opportunity like that every week. Every single week.
Meaning an investor has the chance to “stack up” these more aggressive income trades over and over.
If that sounds interesting… Watch the presentation here |
TGI Triumph Group | Upgraded by | Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $15.40 +6.1% | $18.00 | Peer Perform ➝ Outperform | |
TMDX TransMedics Group | Initiated by | Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $76.90 +3.8% | $95.00 | Overweight | |
TRNO Terreno Realty | Reiterated by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $65.83 +0.8% | $67.00 | Neutral ➝ Neutral | |
TSLA Tesla | Target Lowered by | Deutsche Bank Aktiengesellschaft Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $178.57 -0.7% | $218.00 ➝ $200.00 | Buy | |
TSLA Tesla | Target Lowered by | Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $178.57 -0.7% | $315.00 ➝ $300.00 | Outperform ➝ Outperform | |
UPS United Parcel Service | Target Lowered by | TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $147.79 +0.3% | $147.00 ➝ $140.00 | Hold | |
USB U.S. Bancorp | Upgraded by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $44.58 +1.3% | $47.00 ➝ $53.00 | Hold ➝ Buy | |
VERU Veru | Initiated by | Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $0.69 +6.7% | $3.00 | Outperform | |
VIPS Vipshop | Target Lowered by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $16.51 +0.3% | $22.90 ➝ $19.00 | Hold ➝ Hold | |
VIST Vista Energy | Reiterated by | UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $41.97 -0.6% | $40.00 ➝ $47.00 | Buy ➝ Neutral | |
VNO Vornado Realty Trust | Upgraded by | Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $27.99 +1.9% | $24.00 ➝ $26.00 | Underweight ➝ Equal Weight | |
VRNT Verint Systems | Reiterated by | Needham & Company LLC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.80 +11.9% | $40.00 | Buy ➝ Buy | |
VRNT Verint Systems | Reiterated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $34.80 +11.9% | | Market Perform ➝ Market Perform | |
WB Weibo | Reiterated by | The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $9.46 -0.4% | $10.60 | Buy ➝ Neutral | |
WFC Wells Fargo & Company | Target Raised by | HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $57.92 +0.5% | $55.00 ➝ $60.00 | Hold ➝ Hold | |
XERS Xeris Biopharma | Initiated by | Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating | | $2.22 +8.8% | $5.00 | Outperform | |